Sentinel lymph node biopsy in early stage ovarian cancer: A prospective observational study
- Ayush Heda 1, Shalini Rajaram 1, Anupama Bahadur 2, Amrita Gaurav 1, Latika Chawla 2, Vandana Kumar Dhingra 3, Nilotpal Chowdhury 4, Manishi Narayan 3, Jaya Chaturvedi 2, Ipshita Sahoo 1, Lakhwinder Singh 1
- Ayush Heda 1, Shalini Rajaram 1, Anupama Bahadur 2
- 1Department of Obstetrics and Gynaecology (Gynaecologic Oncology), All India Institute of Medical Sciences, Rishikesh, India.
- 2Department of Obstetrics and Gynaecology, All India Institute of Medical Sciences, Rishikesh, India.
- 3Department of Nuclear Medicine, All India Institute of Medical Sciences, Rishikesh, India.
- 4Department of Pathology and Laboratory Medicine, All India Institute of Medical Sciences, Rishikesh, India.
- 0Department of Obstetrics and Gynaecology (Gynaecologic Oncology), All India Institute of Medical Sciences, Rishikesh, India.
|
March 5, 2025
Related Experiment Videos
Contact us if these videos are not relevant.
Contact us if these videos are not relevant.
View abstract on PubMed
Summary
This summary is machine-generated.Sentinel lymph node biopsy (SLNB) accurately assesses lymph node status in early-stage epithelial ovarian cancer. This technique, using radioactive tracers and blue dye, avoids extensive surgery and identifies isolated tumor cells.
Area Of Science
- Oncology
- Surgical Pathology
Background
- Sentinel lymph node biopsy (SLNB) is crucial for staging various cancers, minimizing morbidity by avoiding complete lymphadenectomy.
- Its role in epithelial ovarian cancer (EOC) requires further evaluation to optimize patient management.
Purpose Of The Study
- To assess the feasibility and accuracy of SLNB in patients with suspected early-stage epithelial ovarian cancer.
- To evaluate the combined use of a radioactive tracer and blue dye for sentinel lymph node identification.
Main Methods
- A prospective observational study involving 29 patients with suspected stage I/II EOC.
- Subperitoneal injection of tracers followed by SLN identification and systematic lymphadenectomy.
- SLNs were subjected to ultrastaging for precise pathological assessment.
Main Results
- A 100% SLN detection rate was achieved using the combination of radioactive tracer and blue dye.
- The SLNB demonstrated 100% sensitivity, specificity, and predictive values when a sentinel node was detected.
- Ultrastaging identified isolated tumor cells (ITCs) in five cases, with no observed complications.
Conclusions
- SLNB is a feasible and accurate method for lymph node staging in epithelial ovarian cancer.
- The combination of tracers enhances detection rates, offering a less invasive staging option.
- While ultrastaging detects ITCs, their clinical significance in EOC warrants further investigation.
Related Experiment Videos
Contact us if these videos are not relevant.
Contact us if these videos are not relevant.

